Loading...
Loading...
Bristol-Myers Squibb Company
BMY will host a teleconference on
Tuesday, September 8 at 8 a.m. EDT (6 a.m. MDT) to review data presented at
the 16(th) Annual World Conference on Lung Cancer (WCLC) in Denver, CO.
Company executives will provide an overview of data presented on our
Immuno-Oncology portfolio at the meeting, and address inquiries from
investors and analysts.
Investors and the general public are invited to listen to a live webcast of
the call at http://investor.bms.com, by dialing U.S. toll-free (877)
201-0168 or international (647) 788-4901, confirmation code: 29586971.
Materials related to the call will be available at the same website prior to
the call. A replay of the call will be available beginning at 10:30 p.m. EDT
on September 8 through 11:59 p.m. EDT on September 23. The replay can be
accessed at http://investor.bms.com or by dialing U.S. toll-free (855)
859-2056 or international (404) 537-3406, confirmation code: 29586971.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In: NewsPress Releases
We simplify the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in